text
"['\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2021년 12월 31일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\nUnins(H.K.) International Limited(*1)\n비상장\n1997.01.01\n경영참여\n549\n4,638,000\n100.00\n159\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 -\n4,638,000\n100.00\n159\n137\n-1\n(주)한독테바\n비상장\n2013.02.21\n경영참여\n7,350\n15,680\n49.00\n23,520\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 -\n15,680\n49.00\n23,520\n23,179\n854\n(주)제넥신\n상장\n2013.10.26\n경영참여\n29,021\n3,781,017\n15.31\n51,859\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 -\n3,781,017\n15.11\n51,859\n639,926\n-44,003\n(주)칼로스메디칼(*2)\n비상장\n2015.10.01\n경영참여\n1,017\n178,862\n49.96\n996\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 -\n178,862\n49.96\n996\n3,018\n-7,334\n㈜엔비포스텍\n비상장\n2016.03.14\n경영참여\n8,400\n1,100,010\n34.99\n3,894\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0-\n\xa0 2,543\n1,100,010\n34.99\n6,437\n4,659\n438\nRezolute, Inc.(*3)\n상장\n2019.01.28\n경영참여\n13,964\n2,015,491\n24.13\n30,035\n\xa0 \xa0 \xa0 769,231\n\xa05,855\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n2,784,722\n17.90\n35,890\n11,930\n-23,994\nJUST-C.INC(*4)\n비상장\n2016.03.08\n경영참여\n3,918\n160,123,077\n94.79\n-\n-160,123,077\n\xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 -\n0.00\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n278\n-188\nTheravalues Corporation\xa0\n비상장\n2016.12.12\n경영참여\n21,304\n1,750,000\n100.00\n25,107\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa0 \xa0 \xa0 \xa0-\n-7,926\n1,750,000\n100.00\n17,181\n5,570\n1,071\nMac Fund, L.P.(*4)\n비상장\n2013.01.08\n단순투자\n1,064\n-\n10.36\n976\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 -\n10.36\n976\n11,498\n899\nTRIGR Therapeutics, Inc.(*5)\n비상장\n2019.03.15\n경영참여\n5,692\n2,500,000\n14.84\n5,692\n-2,500,000\n-5,692\n\xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n0.00\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n481\n-2,463\nRMGP Bio-Pharma Investment Fund L.P\n비상장\n2017.04.28\n단순투자\n4,780\n-\n18.86\n3,910\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 -\n\xa02,782\n-1,397\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n18.86\n5,295\n29,402\n-9,246\nHD Medical, Inc.(*6)\n비상장\n2017.06.28\n일반투자\n568\n188,844\n3.16\n568\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 -\n188,844\n3.16\n568\n393\n-896\nSANA Health. INC.\n비상장\n2018.08.24\n일반투자\n281\n118,021\n1.05\n281\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0 -\n118,021\n1.05\n281\n5,272\n-6,472\nBiomX Ltd.\n상장\n2018.11.16\n일반투자\n2,929\n399,399\n1.79\n2,772\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n-2,015\n399,399\n1.43\n757\n76,555\n-35,503\nSCM생명과학㈜\n상장\n2019.05.24\n일반투자\n4,000\n261,048\n2.64\n12,883\n-120,000\n-2,901\n-7,239\n141,048\n1.17\n2,743\n86,034\n680\nAdicet Bio, Inc.\n상장\n2019.07.25\n일반투자\n3,534\n265,070\n1.35\n4,052\n\xa0 \xa0 \xa0 \xa0 25,384\n\xa0 \xa0371\n\xa0 \xa01,599\n290,454\n0.74\n6,022\n167,372\n-43,281\n인터베스트오픈 이노베이션 사모투자합작회사\n비상장\n2020.12.30\n단순투자\n1,500\n-\n\xa0 \xa0 9.68\n1,500\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 4,500\n-\n-\n6.25\n\xa0 \xa0 \xa0 \xa06,000\n93,474\n-3,740\n웰트㈜\n비상장\n2021.03.24\n일반투자\n\xa0 3,001\n-\n-\n-\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 5,486\n3,001\n-\n5,486\n9.94\n3,001\n11,141\n-1,446\nCompass Therapeutics, Inc.(*5)\n상장\n2021.06.24\n일반투자\n9,094\n-\n-\n-\n\xa0 \xa0 2,032,269\n9,094\n-1,457\n2,032,269\n3.30\n\xa0 \xa0 \xa0 \xa07,637\n56,479\n-34,811\n㈜이노큐브(*7)\n비상장\n2021.09.09\n경영참여\n200\n-\n-\n-\n\xa0 \xa0 \xa0 \xa0 20,000\n\xa0 \xa0200\n-\n20,000\n100.00\n\xa0 \xa0 \xa0 \xa0200\n200\n-91\n스파크바이오파마㈜\n비상장\n2021.11.26\n일반투자\n3,000\n-\n-\n-\n\xa0 \xa0 \xa0 \xa0 46,512\n\xa03,000\n-\n46,512\n2.30\n\xa0 \xa0 \xa0 \xa03,000\n15,166\n-10,075\n합 계\n-\n-\n168,204\n-\n20,210\n-15,892\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n172,522\n\xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0-\n\xa0 \xa0 \xa0 \xa0-\n※ 피출자법인의 최근사업연도 총자산 및 당기순손익은 최근사업연도 기말잔액 및\xa0실적을 기재하였습니다.(*1) Unins(H.K.) International Limited는 3월 결산법인으로 최근사업연도 재무현황은 2021년 3월 31일 기준으로 기재하였습니다.\n(*2) (주)칼로스메디칼 지분율의 경우 우선주를 제외한 비율입니다.(*3) Rezolute, Inc.는 6월 결산법인으로 최근사업연도 재무현황은 2021년 6월 30일 기준으로 기재하였습니다.(*4) JUST-C,INC 및 Mac Fund, L.P.는 청산 완료 및 절차 진행 중에 있습니다.(*5) TRIGR Therapeutics, Inc.는 Compass Therapeutics, Inc.으로 흡수 합병되었습니다.(*6) HD Medical, Inc.,의 경우 최근 사업연도 기말잔액 및 실적 확보가 어려워 확보 가능한 가장 최근의 자료를 기재하였습니다.(*7) ㈜이노큐브는 당기 중 전액 출자하여 설립되었습니다.\n']"
